X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (84) 84
Book / eBook (24) 24
Publication (19) 19
Newspaper Article (18) 18
Magazine Article (8) 8
Dissertation (2) 2
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (54) 54
index medicus (41) 41
male (38) 38
oncology (29) 29
cancer (25) 25
middle aged (24) 24
radiotherapy (24) 24
aged (21) 21
adult (20) 20
female (19) 19
chemotherapy (17) 17
bladder cancer (16) 16
care and treatment (15) 15
aged, 80 and over (13) 13
hematology, oncology and palliative medicine (13) 13
radical cystectomy (13) 13
analysis (12) 12
article (12) 12
radiation (12) 12
animals (11) 11
health aspects (11) 11
mortality (11) 11
patients (11) 11
research (11) 11
urinary bladder neoplasms - therapy (11) 11
prostate cancer (10) 10
prostatic neoplasms - pathology (10) 10
radiation-therapy (10) 10
radiology, nuclear medicine & medical imaging (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
carcinoma (9) 9
mice (9) 9
neoadjuvant chemotherapy (9) 9
neoplasms (9) 9
prostatic neoplasms - radiotherapy (9) 9
radiation therapy (9) 9
radiology (9) 9
radiology and nuclear medicine (9) 9
time factors (9) 9
treatment outcome (9) 9
urology & nephrology (9) 9
cystectomy (8) 8
follow-up studies (8) 8
neoplasm invasiveness (8) 8
neoplasm staging (8) 8
patient outcomes (8) 8
prognosis (8) 8
risk factors (8) 8
surgery (8) 8
therapy (8) 8
urinary bladder neoplasms - pathology (8) 8
adolescent (7) 7
combined modality therapy (7) 7
nuclear radiation (7) 7
studies (7) 7
bladder (6) 6
neurosciences (6) 6
prostate (6) 6
prostatic neoplasms - drug therapy (6) 6
prostatic neoplasms - mortality (6) 6
radiotherapy dosage (6) 6
survival (6) 6
urinary bladder neoplasms - mortality (6) 6
urology (6) 6
cell line, tumor (5) 5
cystectomy - methods (5) 5
dictionaries (5) 5
disease-free survival (5) 5
endocrinology & metabolism (5) 5
hospitals (5) 5
medical research (5) 5
men (5) 5
metastases (5) 5
methods (5) 5
obesity (5) 5
organ sparing treatments - methods (5) 5
physiology (5) 5
prospective studies (5) 5
prostate-specific antigen - blood (5) 5
quality-of-life (5) 5
united states (5) 5
usage (5) 5
abridged index medicus (4) 4
adjuvant chemotherapy (4) 4
adjuvant treatment (4) 4
androgen deprivation (4) 4
antigens (4) 4
biochemistry & molecular biology (4) 4
cancer therapies (4) 4
cell biology (4) 4
chemotherapy, adjuvant (4) 4
clinical trials (4) 4
combined modality therapy - methods (4) 4
combined-modality therapy (4) 4
competing risk (4) 4
diagnosis (4) 4
diseases (4) 4
english language (4) 4
epidemiology (4) 4
genetics & heredity (4) 4
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (8) 8
Gerstein Science - Stacks (7) 7
UTL at Downsview - May be requested (5) 5
UofT at Mississauga - Stacks (5) 5
Victoria University E.J. Pratt - Stacks (3) 3
OISE - Stacks (2) 2
Trinity College (John W Graham) - Reference (2) 2
UofT at Scarborough - Stacks (2) 2
Victoria University E.J. Pratt - Reference (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Robarts - Reference (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's College (John M. Kelly) - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 93, Issue 2, pp. 294 - 302
Purpose Long-term (LT) androgen suppression (AS) with radiation therapy (RT) is a standard treatment of high-risk, localized prostate cancer (PCa). Radiation... 
Radiology | Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | DEPRIVATION | ORAL ETOPOSIDE | GROUP PROTOCOL 92-02 | RADIOTHERAPY | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | III TRIAL | DURATION | ESTRAMUSTINE | PACLITAXEL | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Hormonal - adverse effects | Early Termination of Clinical Trials | Neoplasm Grading | Time Factors | Chemotherapy, Adjuvant - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Adult | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Etoposide - therapeutic use | Paclitaxel - therapeutic use | Disease Progression | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Androgen Antagonists - therapeutic use | Aged | Combined Modality Therapy - methods | Estramustine - therapeutic use | Clinical trials | Radiotherapy | Health aspects | Adjuvant treatment | Radiation | Cancer | Index Medicus | PROSTATE | LUTEINIZING HORMONE | PATIENTS | NEOPLASMS | CLINICAL TRIALS | FAILURES | METASTASES | ANTIGENS | TOXICITY | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | LIBERINS | INHIBITION | DATA | HYPOTHESIS | RADIOLOGY AND NUCLEAR MEDICINE | ANDROGENS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 92, Issue 4, pp. 863 - 873
Purpose The purpose of this study was to assess the association between positive post-radiation therapy (RT) biopsy results and subsequent clinical outcomes in... 
Radiology | Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | ANDROGEN DEPRIVATION | SURVIVAL | BEAM RADIOTHERAPY | DOSE-ESCALATION | MORBIDITY | ONCOLOGY | COMPETING RISK | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIATION-THERAPY | Biopsy - methods | Prostatic Neoplasms - radiotherapy | Adenocarcinoma - pathology | Humans | Middle Aged | Male | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Prostate - pathology | Neoplasm Grading | Aged, 80 and over | Prostatic Neoplasms - blood | Flutamide - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Neoplasm Recurrence, Local - blood | Prostatic Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Prostatic Neoplasms - pathology | Adenocarcinoma - blood | Treatment Outcome | Combined Modality Therapy | Adenocarcinoma - drug therapy | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Disease-Free Survival | Androgen Antagonists - therapeutic use | Aged | Neoplasm Staging | Adenocarcinoma - mortality | Radiotherapy | Sects | Radiation | Pituitary hormones | Analysis | Oncology, Experimental | Luteinizing hormone | Glycoproteins | Research | Cancer | PROSTATE | LUTEINIZING HORMONE | PATIENTS | NEOPLASMS | BIOPSY | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | ANDROGENS | COMPARATIVE EVALUATIONS | LIBERINS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 88, Issue 3, pp. 618 - 623
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 5, pp. 1028 - 1036
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 94, Issue 1, pp. 67 - 74
Purpose To investigate the differences in outcomes among patients with muscle-invasive bladder cancer on NRG Oncology Radiation Therapy Oncology Group... 
Radiology | Hematology, Oncology and Palliative Medicine | SELECTIVE ORGAN PRESERVATION | ADJUVANT CHEMOTHERAPY | CONSERVATION | NEOADJUVANT CHEMOTHERAPY | CISPLATIN | ONCOLOGY | RADICAL CYSTECTOMY | TRANSURETHRAL SURGERY | II TRIAL | RTOG | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIATION-THERAPY | Prospective Studies | Consolidation Chemotherapy - methods | Humans | Middle Aged | Male | Carcinoma, Transitional Cell - therapy | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Cisplatin - administration & dosage | Organ Sparing Treatments - methods | Fluorouracil - administration & dosage | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Paclitaxel - administration & dosage | Radiotherapy Dosage | Chemoradiotherapy - methods | Urinary Bladder Neoplasms - mortality | Neoplasm Invasiveness | Deoxycytidine - administration & dosage | Remission Induction | Cystectomy | Carcinoma, Transitional Cell - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Urinary Bladder Neoplasms - therapy | Aged | Combined Modality Therapy - methods | Deoxycytidine - analogs & derivatives | Salvage Therapy - methods | Sects | Care and treatment | Chemotherapy | Analysis | Patient outcomes | Information management | Bladder cancer | Cancer | PATIENTS | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | BLADDER | RADIOTHERAPY | GY RANGE 10-100 | CHEMOTHERAPY | COMBINED THERAPY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 88, Issue 5, pp. 1048 - 1056
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9685, pp. 239 - 249
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 9, pp. 863 - 872
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 86, Issue 2, pp. 311 - 316
Journal Article